Alexion Pharmaceuticals, Inc.

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

9/29/2021

Shares

40,845

Value ($000)

7,504

Weight

0.0%

2013 Q4 - 2021 Q2 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	9/29/2021	7,504	0.0%	40,845	6/30/2021
2021 Q1	4/30/2021	5,499	0.0%	35,963	3/31/2021
2020 Q4	2/2/2021	5,799	0.0%	37,117	12/31/2020
2020 Q3	11/10/2020	4,383	0.0%	38,299	9/30/2020
2020 Q2	8/12/2020	3,982	0.0%	35,479	6/30/2020
2020 Q1	5/13/2020	2,173	0.0%	24,206	3/31/2020
2019 Q4	2/12/2020	5,714	0.0%	52,837	12/31/2019
2014 Q2	7/7/2014	14,353	0.2%	91,860	6/30/2014
2014 Q1	4/15/2014	14,111	0.2%	92,757	3/31/2014
2013 Q4	1/15/2014	14,212	0.2%	106,950	12/31/2013